Comvita Limited (CVNZF) Fair Value & Analysis
Consumer Defensive · US · Market cap $32.5M
Comvita Limited
CVNZF · US
Fair value as of: Jul 24, 2026
From 9 valuation models · updated 17 days ago
Fair value updated Jul 24, 2026, revised from $1.11 to $1.17 (+5.4%) since Jun 25, 2026.
A solid business, screening 181% undervalued on our models.
What matters now
- The price is below even our cautious bear case ($0.4700). The market is more pessimistic than our downside scenario.
- The model range is unusually wide ($0.4700 to $1.86). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid quality (53/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year. As of Jul 24, 2026.
How to read this chart
60‑month range $0.3447 – $7.27 · fair‑value band $0.4700 – $1.86 · the $0.4161 price screens below the $1.17 fair value. As of Jul 24, 2026.
Analysis
Comvita Limited (CVNZF) currently trades at $0.4161, while our model-based Fair Value estimate is $1.17, implying the stock looks roughly 181.2% undervalued today. The Quality Score stands at 53/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Comvita Limited generated revenue of $211M at a net margin of -44.5%. Revenue grew 18.3% year over year. It earns a return on equity of -89.3%. Net debt stands at $82.7M. Fundamentals as of Jul 24, 2026
Our scenario range runs from $0.4700 (bear case) to $1.86 (bull case); at $0.4161, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 4% below its 52-week high and 32% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 181%, CVNZF screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: Growth DCF ($3.82) versus Dividend Discount ($0.4300). Highest evidence: Growth DCF (80).
Notify me when CVNZF reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 24, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 53 · Market factors (momentum, volatility) 26
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally.
Full company description
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also engages in the apiary ownership and forest management activities. The company sells its products online through its website. Comvita Limited was founded in 1974 and is based in Te Puke, New Zealand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Comvita Limited reported revenue of $192M in FY2025 versus $192M in FY2021, a compound +0.1%/yr. Reported net income was −$105M in FY2025.
Watch CVNZF: get an alert when its fair value changes →
Peer Group
Packaged Foods · 649 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,427 | ₹362.37 | -75% |
| Britannia Industries Limited BRITANNIA | ₹5,413 | ₹1,870 | -65% |
| Tata Consumer Products Limited TATACONSUM | ₹1,089 | ₹327.27 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,650 IDR | 15,757 IDR | +137% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| Patanjali Foods Limited PATANJALI | ₹413.80 | ₹157.04 | -62% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,500 VND | 68,259 VND | +17% |
| PT Mayora Indah Tbk, MYOR | 1,750 IDR | 2,699 IDR | +54% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,490 IDR | 4,355 IDR | -3% |
| Nongshim Co 004370 | 348,500 KRW | 530,619 KRW | +52% |
Compare Comvita Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Comvita Limited (CVNZF) overvalued or undervalued?
What is the fair value of CVNZF?
What is the quality score of CVNZF?
What is the revenue of Comvita Limited (CVNZF)?
What is the net profit margin of CVNZF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Comvita Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.